The latest closing stock price for Spyre Therapeutics as of June 20, 2025 is 15.01.
An investor who bought $1,000 worth of Spyre Therapeutics stock at the IPO in 2016 would have $-939 today, roughly -1 times their original investment - a -26.65% compound annual growth rate over 9 years.
The all-time high Spyre Therapeutics stock closing price was 299.75 on April 08, 2016.
The Spyre Therapeutics 52-week high stock price is 40.26, which is 168.2% above the current share price.
The Spyre Therapeutics 52-week low stock price is 10.91, which is 27.3% below the current share price.
The average Spyre Therapeutics stock price for the last 52 weeks is 23.49.
An investor who bought $1,000 worth of Spyre Therapeutics stock at the IPO in 2016 would have $-939 today, roughly -1 times their original investment - a -26.65% compound annual growth rate over 9 years.
The all-time high Spyre Therapeutics stock closing price was 299.75 on April 08, 2016.
The Spyre Therapeutics 52-week high stock price is 40.26, which is 168.2% above the current share price.
The Spyre Therapeutics 52-week low stock price is 10.91, which is 27.3% below the current share price.
The average Spyre Therapeutics stock price for the last 52 weeks is 23.49.